HAART is effective as anti-Kaposi's sarcoma therapy only after remission has been induced by chemotherapy [2]

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 22, Issue 4, 1999, Pages 407-408

  Vaccher, E ^a   Di Gennaro, G ^a   Nasti, G ^a   Juzbasic, S ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ENZYME INHIBITOR;

ANTIVIRAL ACTIVITY; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL; VIRUS REPLICATION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG THERAPY, COMBINATION; HUMANS; MALE; PACLITAXEL; REVERSE TRANSCRIPTASE INHIBITORS; SARCOMA, KAPOSI; VINBLASTINE;

EID: 0033451181     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (10)